Mark J. Vignola - Net Worth and Insider Trading
Mark J. Vignola Net Worth
The estimated net worth of Mark J. Vignola is at least $92,915 dollars as of 2024-05-01. Mark J. Vignola is the CFO of Terns Pharmaceuticals Inc and owns about 18,399 shares of Terns Pharmaceuticals Inc (TERN) stock worth over $92,915. Details can be seen in Mark J. Vignola's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark J. Vignola has not made any transactions after 2023-11-30 and currently still holds the listed stock(s).
Transaction Summary of Mark J. Vignola
Mark J. Vignola Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark J. Vignola owns 2 companies in total, including Applied Therapeutics Inc (APLT) , and Terns Pharmaceuticals Inc (TERN) .
Click here to see the complete history of Mark J. Vignola’s form 4 insider trades.
Insider Ownership Summary of Mark J. Vignola
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
APLT | Applied Therapeutics Inc | 2019-05-13 | Chief Financial Officer |
TERN | Terns Pharmaceuticals Inc | 2023-11-30 | Chief Financial Officer |
Mark J. Vignola Latest Holdings Summary
Mark J. Vignola currently owns a total of 1 stock. Mark J. Vignola owns 18,399 shares of Terns Pharmaceuticals Inc (TERN) as of November 30, 2023, with a value of $92,915.
Latest Holdings of Mark J. Vignola
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TERN | Terns Pharmaceuticals Inc | 2023-11-30 | 18,399 | 5.05 | 92,915 |
Holding Weightings of Mark J. Vignola
Mark J. Vignola Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark J. Vignola has made a total of 4 transactions in Terns Pharmaceuticals Inc (TERN) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Terns Pharmaceuticals Inc is the acquisition of 743 shares on November 30, 2023, which cost Mark J. Vignola around $2,809.
Insider Trading History of Mark J. Vignola
- 1
Mark J. Vignola Trading Performance
GuruFocus tracks the stock performance after each of Mark J. Vignola's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark J. Vignola is 42.02%. GuruFocus also compares Mark J. Vignola's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark J. Vignola within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark J. Vignola's insider trading performs compared to the benchmark.
Performance of Mark J. Vignola
Average Return
235.28%
Outperforming Transactions
50%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 28.71 | 42.02 | 96 | 235.28 | ||
Relative Return to S&P 500(%) | 29.32 | 38.62 | 92.12 | 228.73 |
Mark J. Vignola Ownership Network
Ownership Network List of Mark J. Vignola
Ownership Network Relation of Mark J. Vignola
Mark J. Vignola Owned Company Details
What does Applied Therapeutics Inc do?
Who are the key executives at Applied Therapeutics Inc?
Mark J. Vignola is the Chief Financial Officer of Applied Therapeutics Inc. Other key executives at Applied Therapeutics Inc include director & 10 percent owner & President and CEO Shoshana Shendelman , Chief Commercial Officer Adam Hansard , and Chief Medical Officer Riccardo Perfetti .
Applied Therapeutics Inc (APLT) Insider Trades Summary
Over the past 18 months, Mark J. Vignola made no insider transaction in Applied Therapeutics Inc (APLT). Other recent insider transactions involving Applied Therapeutics Inc (APLT) include a net sale of 454,043 shares made by Shoshana Shendelman , a net sale of 129,372 shares made by Riccardo Perfetti , and a net sale of 64,051 shares made by Adam Hansard .
In summary, during the past 3 months, insiders sold 506,975 shares of Applied Therapeutics Inc (APLT) in total and bought 0 shares, with a net sale of 506,975 shares. During the past 18 months, 1,251,193 shares of Applied Therapeutics Inc (APLT) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 1,221,193 shares.
Applied Therapeutics Inc (APLT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Applied Therapeutics Inc Insider Transactions
Mark J. Vignola Mailing Address
Above is the net worth, insider trading, and ownership report for Mark J. Vignola. You might contact Mark J. Vignola via mailing address: C/o Applied Therapeutics, Inc., 340 Madison Avenue, 19th Floor, New York Ny 10173.